The p53 pathway: Positive and negative feedback loops

Oncogene

Volumn 24, Issue 17, 2005, Pages 2899-2908

  Harris, Sandra L ^a   Levine, Arnold J ^a  

^a RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Autoregulatory; Feedback loops; p53

Indexed keywords

ARF PROTEIN; BETA CATENIN; COP 1 PROTEIN; CYCLIN DEPENDENT KINASE; CYCLIN G1; CYCLINE; GENE PRODUCT; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHOPROTEIN; PHOSPHOPROTEIN 2A; PIRH 2 PROTEIN; PROTEIN KINASE B; PROTEIN MDM2; PROTEIN P14; PROTEIN P19; PROTEIN P53; PROTEIN P73; RETINOBLASTOMA PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F; UBIQUITIN PROTEIN LIGASE; UNCLASSIFIED DRUG; WNT PROTEIN;

APOPTOSIS; AUTOREGULATION; CANCER; CELL AGING; CELL CYCLE; CELL CYCLE ARREST; CELL DIVISION; CELL SENESCENCE; CELL TYPE; DNA REPLICATION; FEEDBACK SYSTEM; GENE; NEGATIVE FEEDBACK; POSITIVE FEEDBACK; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PROCESSING; REVIEW; SIGNAL TRANSDUCTION; STRESS; SYSTEMATIC REVIEW; TRANSCRIPTION REGULATION; AMINO ACID SEQUENCE; ANIMAL; CHEMISTRY; HUMAN; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; FEEDBACK; HUMANS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 18344377030     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208615     Document Type: Review

References (83)

1. Appella E and Anderson CW. (2001). Eur. J. Biochem., 268, 2764-2772.
2. Bates S, Phillips AC, Clark PA, Stott F, Peters G, Ludwig RL and Vousden KH. (1998). Nature, 395, 124-125.
3. Bates S, Rowan S and Vousden KH. (1996). Oncogene, 13, 1103-1109.
4. Bennett M, Macdonald K, Chan SW, Luzio JP, Simari R and Weissberg P. (1998). Science, 282, 290-293.
5. Bergamaschi D, Gasco M, Hiller L, Sullivan A, Syed N, Trigiante G, Yulug I, Merlano M, Numico G, Comino A, Attard M, Reelfs O, Gusterson B, Bell AK, Heath V, Tavassoli M, Farrell PJ, Smith P, Lu X and Crook T. (2003). Cancer Cell, 3, 387-402.
6. Blander G, Zalle N, Leal JF, Bar-Or RL, Yu CE and Oren M. (2000). FASEB J., 14, 2138-2140.
7. Blandino G, Levine AJ and Oren M. (1999). Oncogene, 18, 477-485.
8. Bullock AN, Henckel J and Fersht AR. (2000). Oncogene, 19, 1245-1256.
9. Colman MS, Afshari CA and Barrett JC. (2000). Mutat. Res., 462, 179-188.
10. Dai MS and Lu H. (2004). J. Biol. Chem., 279, 44475-44482.
11. Dai MS, Zeng SX, Jin Y, Sun XX, David L and Lu H. (2004). Mol. Cell Biol., 24, 7654-7668.
12. Damalas A, Kahan S, Shtutman M, Ben-Ze'ev A and Oren M. (2001). EMBO J., 20, 4912-4922.
13. Datta A, Nag A, Pan W, Hay N, Cartel AL, Colamonici O, Mori Y and Raychaudhuri P. (2004). J. Biol. Chem., 279, 36698-36707.
14. de Stanchina E, McCurrach ME, Zindy F, Shieh SY, Ferbeyre G, Samuelson AV, Prives C, Roussel MF, Sherr CJ and Lowe SW. (1998). Genes Dev., 12, 2434-2442.
15. de Vries A, Flores ER, Miranda B, Hsieh HM, van Oostrom CT, Sage J and Jacks T. (2002). Proc. Natl. Acad. Sci. USA, 99, 2948-2953.
16. Dittmer D, Pati S, Zambetti G, Chu S, Teresky AK, Moore M, Finlay C and Levine AJ. (1993). Nat. Genet., 4, 42-46.
17. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H and Dixit VM. (2004). Nature, 429, 86-92.
18. Elenbaas B, Dobbelstein M, Roth J, Shenk T and Levine AJ. (1996). Mol. Med., 2, 439-451.
19. Epstein CB, Attiyeh EF, Hobson DA, Silver AL, Broach JR and Levine AJ. (1998). Oncogene, 16, 2115-2122.
20. Erster S, Mihara M, Kim RH, Petrenko O and Moll UM. (2004). Mol. Cell. Biol., 24, 6728-6741.
21. Fiucci G, Beaucourt S, Duflaut D, Lespagnol A, Stumptner-Cuvelette P, Geant A, Buchwalter G, Tuynder M, Susini L, Lassalle JM, Wasylyk C, Wasylyk B, Oren M, Amson R and Teleman A. (2004). Proc. Natl. Acad. Sci. USA. 101, 3510-3515.
22. Freedman DA, Epstein CB, Roth JC and Levine AJ. (1997). Mol. Med., 3, 248-259.
23. Gaiddon C, Lokshin M, Ahn J, Zhang T and Prives C. (2001). Mol. Cell. Biol., 21, 1874-1887.
24. Giaccia AJ and Kastan MB. (1998). Genes Dev., 12, 2973-2983.
25. Gottlieb TM, Leal JF, Seger R, Taya Y and Oren M. (2002). Oncogene, 21, 1299-1303.
26. Grob TJ, Novak U, Maisse C, Barcaroli D, Luthi AU, Pirnia F, Hugli B, Graber HU, De Laurenzi V, Fey MF, Melino G and Tobler A. (2001). Cell Death Differ., 8, 1213-1223.
27. Gudkov AV and Komarova EA. (2003). Nat. Rev. Cancer, 3, 117-129.
28. Harms K, Nozell S and Chen X. (2004). Cell Mol. Life Sci., 61, 822-842.
29. Haupt Y, Rowan S, Shaulian E, Kazaz A, Vousden K and Oren M. (1997). Leukemia, 11 (Suppl 3), 337-339.
30. Hoh J, Jin S, Parrado T, Edington J, Levine AJ and Ott J. (2002). Proc. Natl Acad. Sci. USA, 99, 8467-8472.
31. Honda R and Yasuda H. (1999). EMBO J., 18, 22-27.
32. Iliakis G, Wang Y, Guan J and Wang H. (2003). Oncogene, 22, 5834-5847.
33. Iwai A, Marusawa H, Matsuzawa SI, Fukushima T, Hijikata M, Reed JC, Shimotohno K and Chiba T. (2004). Oncogene, 23, 7593-7600.
34. Jin S and Levine AJ. (2001). J. Cell Sci., 114, 4139-4140.
35. Jones SN, Roe AE, Donehower LA and Bradley A. (1995). Nature, 378, 206-208.
36. Jost CA, Marin MC and Kaelin Jr WG. (1997). Nature, 389, 191-194.
37. Kaghad M, Bonnet H, Yang A, Creancier L, Biscan JC, Valent A, Minty A, Chalon P, Lelias JM, Dumont X, Ferrara P, McKeon F and Caput D. (1997). Cell, 90, 809-819.
38. Kartasheva NN, Contente A, Lenz-Stoppler C, Roth J and Dobbelstein M. (2002). Oncogene, 21, 4715-4727.
39. Kern SE, Kinzler KW, Baker SJ, Nigro JM, Rotter V, Levine AJ, Friedman P, Prives C and Vogelstein B. (1991). Oncogene, 6, 131-136.
40. Kimura SH, Ikawa M, Ito A, Okabe M and Nojima H. (2001). Oncogene, 20, 3290-3300.
41. Klein C and Vassilev LT. (2004). Br. J. Cancer, 91, 1415-1419.
42. Komarova EA, Diatchenko L, Rokhlin OW, Hill JE, Wang ZJ, Krivokrysenko VI, Feinstein E and Gudkov AV. (1998). Oncogene, 17, 1089-1096.
43. Kussie PH, Gorina S, Marechal V, Elenbaas B, Moreau J, Levine AJ and Pavletich NP. (1996). Science, 274, 948-953.
44. Lahav G, Rosenfeld N, Sigal A, Geva-Zatorsky N, Levine AJ, Elowitz MB and Alon U. (2004). Nat. Genet., 36, 147-150.
45. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R and Benchimol S. (2003). Cell, 112, 779-791.
46. Lev Bar-Or R, Maya R, Segel LA, Alon U, Levine AJ and Oren M. (2000). Proc. Natl. Acad. Sci. USA, 97, 11250-11255.
47. Lin J, Chen J, Elenbaas B and Levine AJ. (1994). Genes Dev., 8, 1235-1246.
48. Lohrum MA, Ludwig RL, Kubbutat MH, Hanlon M and Vousden KH. (2003). Cancer Cell, 3, 577-587.
49. Lotem J, Gal H, Kama R, Amariglio N, Rechavi G, Domany E, Sachs L and Givol D. (2003). Proc. Natl. Acad. Sci. USA, 100, 6718-6723.
50. Louria-Hayon I, Grossman T, Sionov RV, Alsheich O, Pandolfi PP and Haupt Y. (2003). J. Biol. Chem., 278, 33134-33141.
51. Lowe SW and Sherr CJ. (2003). Curr. Opin. Genet. Dev., 13, 77-83.
52. Malkin D, Li FP, Strong LC, Fraumeni Jr JF, Nelson CE, Kim DH, Kassel J, Gryka MA, Bischoff FZ and Tainsky MA. (1990). Science, 250, 1233-1238.
53. Marechal V, Elenbaas B, Piette J, Nicolas JC and Levine AJ. (1994). Mol. Cell. Biol., 14, 7414-7420.
54. Marin MC, Jost CA, Brooks LA, Irwin MS, O'Nions J, Tidy JA, James N, McGregor JM, Harwood CA, Yulug IG, Vousden KH, Allday MJ, Gusterson B, Ikawa S, Hinds PW, Cook T and Kalin Jr WG. (2000). Nat. Genet., 25, 47-54.
55. Montes de Oca Luna R, Wagner DS and Lozano G. (1995). Nature, 378, 203-206.
56. Mothersill C and Seymour CB. (2004). Nat. Rev. Cancer. 4, 158-164.
57. Nakamura Y. (2004). Cancer Sci., 95, 7-11.
58. Nishizaki M, Fujiwara T, Tanida T, Hizuta A, Nishimori H, Tokino T, Nakamura Y, Bouvet M, Roth JA and Tanaka N. (1999). Clin. Cancer Res., 5, 1015-1023.
59. Okamoto K and Beach D. (1994). EMBO J., 13, 4816-4822.
60. Okamoto K, Li H, Jensen MR, Zhang T, Taya Y, Thorgeirsson SS and Prives C. (2002). Mol. Cell, 9, 761-771.
61. Oren M. (2003). Cell Death Differ., 10, 431-442.
62. Overholtzer M, Rao PH, Favis R, Lu XY, Elowitz MB, Barany F, Ladanyi M, Gorlick R and Levine AJ. (2003). Proc. Natl. Acad. Sci. USA, 100, 11547-11552.
63. Palmero I, Pantoja C and Serrano M. (1998). Nature, 395, 125-126.
64. Rajendra R, Malegaonkar D, Pungaliya P, Marshall H, Rasheed Z, Brownell J, Liu LF, Lutzker S, Saleem A and Rubin EH. (2004). J. Biol. Chem., 279, 36440-36444.
65. Schuler M, Bossy-Wetzel E, Goldstein JC, Fitzgerald P and Green DR. (2000). J. Biol. Chem., 275, 7337-7342.
66. Scott ML, Fujita T, Liou HC, Nolan GP and Baltimore D. (1993). Genes Dev., 7, 1266-1276.
67. Shaulian E, Zauberman A, Ginsberg D and Oren M. (1992). Mol. Cell. Biol., 12, 5581-5592.
68. Stott FJ, Bates S, James MC, McConnell BB, Starborg M, Brookes S, Palmero I, Ryan K, Hara E, Vousden KH and Peters G. (1998). EMBO J., 17, 5001-5014.
69. Sugimoto M, Kuo ML, Roussel MF and Sherr CJ. (2003). Mol. Cell, 11, 415-424.
70. Takekawa M, Adachi M, Nakahata A, Nakayama I, Itoh F, Tsukuda H, Taya Y and Imai K. (2000). EMBO J., 19, 6517-6526.
71. Vaziri H. (1997). Biochemistry (Mosc.), 62, 1306-1310.
72. Vogelstein B, Lane D and Levine AJ. (2000). Nature, 408, 307-310.
73. Wu X and Levine AJ. (1994). Proc. Natl. Acad. Sci. USA, 91, 3602-3606.
74. Xiao ZX, Chen J, Levine AJ, Modjtahedi N, Xing J, Sellers WR and Livingston DM. (1995). Nature, 375, 694-698.
75. Yamasaki L. (2003). Cancer Treat. Res., 115, 209-239.
76. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D and McKeon F. (1998). Mol. Cell, 2, 305-316.
77. Yardley G, Zauberman A, Oren M and Jackson P. (1998). FEBS Lett., 430, 171-175.
78. Zauberman A, Lupo A and Oren M. (1995). Oncogene, 10, 2361-2366.
79. Zhang T and Prives C. (2001). J. Biol. Chem., 276, 29702-29710.
80. Zhang Y, Wolf GW, Bhat K, Jin A, Allio T, Burkhart WA and Xiong Y. (2003). Mol. Cell. Biol., 23, 8902-8912.
81. Zhu H, Wu L and Maki CG. (2003). J. Biol. Chem., 278, 49286-49292.
82. Zhu JW, DeRyckere D, Li FX, Wan YY and DeGregori J. (1999). Cell Growth Differ., 10, 829-838.
83. Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ and Roussel MF. (1998). Genes Dev., 12, 2424-2433.